| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/12/2011 | EP2271213A1 Methods for treating a condition characterized by dysfunction in protein homeostasis |
| 01/12/2011 | EP2089368B1 Diaminocyclohexane and diaminocyclopentane derivatives |
| 01/12/2011 | EP1896435B1 Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors |
| 01/12/2011 | EP1517907B1 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
| 01/12/2011 | EP1439863B1 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 01/12/2011 | EP1402266B1 Reducing RISK OF COMPLICATIONS OF PREMATURITY |
| 01/12/2011 | CN201701876U Membrane separating system for extracting bioactive compositions from bamboo leaves |
| 01/12/2011 | CN1982336B Human pancreas glucagon sample peptide-1-derivative, its production and use |
| 01/12/2011 | CN1923229B Pharmaceutical composition comprising notoginseng extract, Danshen extract and puerarin |
| 01/12/2011 | CN101945871A Imidazo [1,2-a] pyridine compounds |
| 01/12/2011 | CN101945858A Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/12/2011 | CN101945852A Azetidine derivatives, their preparation and their application in therapy |
| 01/12/2011 | CN101942034A Non-insulin-dependent diabetes mellitus-resisting liriope spicata fructosan and preparation method and application thereof |
| 01/12/2011 | CN101942010A Method for promoting solid phase synthesis of balsam pear MC-JJ0106 polypeptide analogue by microwaves and application thereof |
| 01/12/2011 | CN101942003A Compound and preparation method thereof |
| 01/12/2011 | CN101941994A Method for preparing selenium manno-oligosaccharide |
| 01/12/2011 | CN101940785A Hydrogen sulfide-producing enzyme preparation and use thereof |
| 01/12/2011 | CN101940716A Medicament for treating diabetic nephropathy |
| 01/12/2011 | CN101940715A Traditional Chinese medicinal preparation for treating hyperlipidemia |
| 01/12/2011 | CN101940714A Anti-aging and anti-diabetic medicinal wine and preparation method thereof |
| 01/12/2011 | CN101940712A Lipid-lowering weight-losing medicated wine and preparation method thereof |
| 01/12/2011 | CN101940705A Traditional Chinese medicine for treating diabetic heart disease |
| 01/12/2011 | CN101940674A Chinese medicament for treating diabetic peripheral neuropathy |
| 01/12/2011 | CN101940666A Traditional Chinese medicine composite for treating hyperlipoidemia and preparation method thereof |
| 01/12/2011 | CN101940660A Chinese medicament for treating diabetic retinopathy |
| 01/12/2011 | CN101940659A Traditional Chinese medicine for treating diabetic eye disease |
| 01/12/2011 | CN101940637A Method for processing powder for treating hyperlipidemia |
| 01/12/2011 | CN101940626A Chinese medicinal formula preparation for nourishing kidney, removing heat from liver, reducing glucose and regulating lipid and preparation method thereof |
| 01/12/2011 | CN101940620A Medicinal composition for treating diabetes mellitus and application thereof |
| 01/12/2011 | CN101940616A Preparation method of effective part of Clinopodium chinense (Benth.) O. Kuntze for preventing and treating diabetes and medicine application thereof |
| 01/12/2011 | CN101940614A Application of juglans mandshurica maxim. ethyl acetate part in preparing alpha-glucosidase inhibitor medicament |
| 01/12/2011 | CN101940608A Compound red yeast capsule |
| 01/12/2011 | CN101940604A Antilipemic and antioxidant activities of different extracts of hemiptelea and application in medicine |
| 01/12/2011 | CN101940580A Health promotion wine for regulating blood fat and preparation method thereof |
| 01/12/2011 | CN101940578A Medicament composition for curing type 2 diabetes and preparation method thereof |
| 01/12/2011 | CN101940576A Compound and medicinal use thereof |
| 01/12/2011 | CN101940571A Anti-angiogenic agents and methods of use |
| 01/12/2011 | CN101940567A Fish medicament for treating vitamin C and vitamin E deficiency diseases |
| 01/12/2011 | CN101940557A Method for preparing fat-soluble vitamin freeze-dried powder injection |
| 01/12/2011 | CN101518622B Traditional Chinese medicine for treating diabetes complicated with urinary infection |
| 01/12/2011 | CN101417056B Traditional Chinese medicine decoction for treating obesity |
| 01/12/2011 | CN101357921B New dipeptidase-IV inhibitor compound |
| 01/12/2011 | CN101331924B Method for producing inulin syrupy using waste fluid of producing inulin |
| 01/12/2011 | CN101327214B Medicine use of isoquinoline alkaloids as tissue factor inhibitor |
| 01/12/2011 | CN101244120B Method for preparing sianchau particle medicinal granules with multiple health care functions |
| 01/12/2011 | CN101176769B Pharmaceutical composition of cattail pollen and red orpin |
| 01/12/2011 | CN101167775B Method for extracting chrysanthemum total flavone |
| 01/12/2011 | CN101148473B Recombination human insulin and its coding gene and application |
| 01/12/2011 | CN101094851B Novel compound having lipase inhibitory activity |
| 01/12/2011 | CN101029081B Recombinant incretin peptide and method for constructing and culturing producing strain |
| 01/12/2011 | CN101010276B Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 01/11/2011 | US7868225 Artichoke hybrid named ‘PS-H2015’ |
| 01/11/2011 | US7868002 Deazapurines and uses thereof |
| 01/11/2011 | US7867973 comprises follistatin domain I; free of an amino acid sequence represented by formula (I): Cys-(X1)a-Cys-(X2)b-Cys-(X3)c-Cys-(X4)d-Cys-(X5)e-Cys-(X6)f-Cys-(X7)g-Cys-(X8)h-Cys-(X9)i-Cys [x=natural amino acids]; inhibiting GDF-8 activity without inhibiting activin activity |
| 01/11/2011 | CA2502703C A natural compound for prevention and treatment of diabetes, process for preparing the same, and pharmaceutical use thereof |
| 01/11/2011 | CA2471766C Compositions for improving lipid metabolism |
| 01/11/2011 | CA2462390C Anthranilic acid amides and pharmaceutical use thereof |
| 01/11/2011 | CA2453974C 4-(benzylideneamino)-3-(methylsulfanyl)-4h-1,2,4-triazin-5-one derivatives having a pde iv-inhibiting and tnf-antagonistic action for the treatment of heart diseases and allergies |
| 01/11/2011 | CA2430124C Lactam compounds and pharmaceutical use thereof |
| 01/11/2011 | CA2429781C Linkable sialyl lewis x analogs |
| 01/11/2011 | CA2420592C Fused pyrrolocarbazoles against inflammation |
| 01/11/2011 | CA2411778C Organic compounds |
| 01/11/2011 | CA2400486C Aniline-derived ligands for the thyroid receptor |
| 01/11/2011 | CA2387095C Compound with growth hormone releasing properties |
| 01/11/2011 | CA2372063C Pyridopyranoazepine derivatives, their preparation and their therapeutic application |
| 01/11/2011 | CA2328990C N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 01/11/2011 | CA2286313C Novel ldl-receptor |
| 01/06/2011 | WO2011003062A2 Probiotic compositions and processes thereof |
| 01/06/2011 | WO2011002910A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/06/2011 | WO2011002070A1 Pharmaceutical composition for treating iron overload disorders or diseases on which the reduction in iron concentration is effective, which comprises gdf7/bmp12 protein |
| 01/06/2011 | WO2011002066A1 Peptide and use thereof |
| 01/06/2011 | WO2011002033A1 Glucose metabolism-improving agent and glucose metabolism-improving composition |
| 01/06/2011 | WO2011002012A1 Medicinal agent comprising combination of sglt1 inhibitor and insulin-resistance-ameliorating agent |
| 01/06/2011 | WO2011002011A1 Combined medicine of sglt1 inhibitor and dpp-iv inhibitor |
| 01/06/2011 | WO2011002001A1 Combined medicine of pyrazole derivative and biguanide drug |
| 01/06/2011 | WO2011001913A1 Ppar ligand |
| 01/06/2011 | WO2011001441A1 A composition of extract of emblica officinalis and method of preparing the same |
| 01/06/2011 | WO2011000823A1 Insulin derivatives |
| 01/06/2011 | WO2011000563A1 Eltoprazine for the treatment of weight disorders |
| 01/06/2011 | WO2010130785A3 Novel use of probiotics |
| 01/06/2011 | WO2010130773A3 Benzoxazolone derivatives as aldosterone symthase inhibitors |
| 01/06/2011 | WO2010098625A3 Pharmaceutical preparation |
| 01/06/2011 | WO2010090758A3 Diabetes diagnostic, prophylactic, and therapeutic compositions and methods |
| 01/06/2011 | WO2010075010A3 Oligosaccharide-protein conjugates |
| 01/06/2011 | WO2010070618A3 A microencapsulation process of sertoli cells, microcapsules obtained and their use for prevention and cure of type 1 diabetes mellitus |
| 01/06/2011 | US20110004949 Immunoglobulin 1 |
| 01/06/2011 | US20110004948 Immunoglobulin 2 |
| 01/06/2011 | US20110003896 Dimeric double metal salts of (-)-hydroxycitric acid, methods of making and uses of same |
| 01/06/2011 | US20110003874 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 01/06/2011 | US20110003860 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 01/06/2011 | US20110003856 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 01/06/2011 | US20110003853 Metalloproteinase Inhibitors |
| 01/06/2011 | US20110003852 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 01/06/2011 | US20110003849 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment |
| 01/06/2011 | US20110003845 Substituted azabicyclic compounds and the use thereof |
| 01/06/2011 | US20110003837 Modified release formulations of hmg coa reductase inhibitors |
| 01/06/2011 | US20110003828 Prodrugs of nh-acidic compounds |
| 01/06/2011 | US20110003824 Caspase Inhibitors and Uses Thereof |
| 01/06/2011 | US20110003808 Octahydroquinolizines for antidiabetic treatment |
| 01/06/2011 | US20110003797 HEXAHYDROCYCLOPENTYL[f]INDAZOLE CARBOXAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |